A comparison of B16 melanoma cells and 3T3 fibroblasts concerning cell viability and ROS production in the presence of melatonin, tested over a wide range of concentrations

International Journal of Molecular Sciences

Volumn 14, Issue 2, 2013, Pages 3901-3920

  Bonmati Carrion, Maria Angeles ^a   Álvarez Sánchez, Nuria ^b,c   Hardeland, Rüdiger ^d   Madrid, Juan Antonio ^a   Rol, Maria Angeles ^a  

^a UNIVERSITY OF MURCIA   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^c UNIVERSITY OF SEVILLE   (Spain)

^d UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Cell viability; Fibroblast; In vitro; Intracellular ROS; Melanoma; Melatonin; Non tumor cell cultures; Tumor cell cultures

Indexed keywords

MELATONIN; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CELL PROLIFERATION; CELL STRAIN 3T3; CELL VIABILITY; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; FIBROBLAST; HORMONE ACTION; IN VITRO STUDY; MELANOMA B16; MELANOMA CELL; MOUSE; NONHUMAN;

EID: 84875116145     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms14023901     Document Type: Article

References (76)

1. Hardeland, R. Melatonin: Signaling mechanisms of a pleiotropic agent. Biofactors 2009, 35, 183-192.
2. Hardeland, R.; Cardinali, D.P.; Srinivasan, V.; Spence, D.W.; Brown, G.M.; Pandi-Perumal, S.R. Melatonin-A pleiotropic, orchestrating regulator molecule. Prog. Neurobiol. 2011, 93, 350-384.
3. Sanchez-Hidalgo, M.; Alarcon de la Lastra, C.; Carrascosa-Salmoral, M.P.; Naranjo, M.C.; Gomez-Corvera, A.; Caballero, B.; Guerrero, J.M. Age-related changes in melatonin synthesis in rat extrapineal tissues. Exp. Gerontol. 2009, 44, 328-334.
4. Koch, B.C.; Nagtegaal, J.E.; Kerkhof, G.A.; ter Wee, P.M. Circadian sleep-wake rhythm disturbances in end-stage renal disease. Nat. Rev. Nephrol. 2009, 5, 407-416.
5. Hardeland, R.; Madrid, J.A.; Tan, D.X.; Reiter, R.J. Melatonin, the circadian multioscillator system and health: The need for detailed analyses of peripheral melatonin signaling. J. Pineal. Res. 2012, 52, 139-166.
6. Carrillo-Vico, A.; Guerrero, J.M.; Lardone, P.J.; Reiter, R.J. A review of the multiple actions of melatonin on the immune system. Endocrine 2005, 27, 189-200.
7. Reiter, R.J.; Tan, D.X.; Burkhardt, S. Reactive oxygen and nitrogen species and cellular and organismal decline: Amelioration with melatonin. Mech. Ageing Dev. 2002, 123, 1007-1019.
8. Otalora, B.B.; Madrid, J.A.; Alvarez, N.; Vicente, V.; Rol, M.A. Effects of exogenous melatonin and circadian synchronization on tumor progression in melanoma-bearing C57BL6 mice. J. Pineal. Res. 2008, 44, 307-315.
9. Cutando, A.; López-Valverde, A.; Arias-Santiago, S.; de Vicente, J.; de Diego, R.G. Role of melatonin in cancer treatment. Anticancer Res. 2012, 32, 2747-2753.
10. Ghislin, S.; Deshayes, F.; Lauriol, J.; Middendorp, S.; Martins, I.; Al-Daccak, R.; Alcaide-Loridan, C. Plasticity of melanoma cells induced by neural cell crest conditions and three-dimensional growth. Melanoma Res. 2012, 22, 184-194.
11. Blask, D.E.; Sauer, L.A.; Dauchy, R.; Holowachuk, E.W.; Ruhoff, M.S. New actions of melatonin on tumor metabolism and growth. Biol. Signals Recept 1999, 8, 49-55.
12. Cabrera, J.; Negrín, G.; Estévez, F.; Loro, J.; Reiter, R.J.; Quintana, J. Melatonin decreases cell proliferation and induces melanogenesis in human melanoma SK-MEL-1 cells. J. Pineal. Res. 2010, 49, 45-54.
13. Hill, S.M.; Blask, D.E.; Xiang, S.; Yuan, L.; Mao, L.; Dauchy, R. T; Dauchy, E.M.; Frasch, T., Duplesis; T. Melatonin and associated signaling pathways that control normal breast epithelium and breast cancer. J. Mammary Gland Biol. Neoplasia 2011, 16, 235-245.
14. Margheri, M.; Pacini, N.; Tani, A.; Nosi, D.; Squecco, R.; Dama, A.; Masala, E.; Francini, F.; Zecchi-Orlandini, S.; Formigli, L. Combined effects of melatonin and all-trans retinoic acid and somatostatin on breast cancer cell proliferation and death: Molecular basis for the anticancer effect of these molecules. Eur. J. Pharmacol. 2012, 681, 34-43.
15. Shiu, S.Y.; Leung, W.Y.; Tam, C.W.; Liu, V.W.; Yao, K.M. Melatonin MT1 receptor-induced transcriptional up-regulation of p27(Kip1) in prostate cancer antiproliferation is mediated via inhibition of constitutively active nuclear factor kappa B (NF-κB): Potential implications on prostate cancer chemoprevention and therapy. J. Pineal. Res. 2012, doi:10.1111/j.1600-079X.2012.01026.x.
16. Martín-Renedo, J.; Mauriz J.L.; Jorquera, F.; Ruiz-Andrés, O.; González, P.; González-Gallego, J. Melatonin induces cell cycle arrest and apoptosis in hepatocarcinoma HepG2 cell line. J. Pineal. Res. 2008, 45, 532-540.
17. Carbajo-Pescador, S.; Martín-Renedo, J.; García-Palomo, A.; Tuñón, M.J.; Mauriz, J.L.; González-Gallego, J. Changes in the expression of melatonin receptors induced by melatonin treatment in hepatocarcinoma HepG2 cells. J. Pineal. Res. 2009, 47, 330-338.
18. Radogna, F.; Paternoster, L.; Albertini, M.C.; Accorsi, A., Cerella, C.; D'Alessio, M.; de Nicola, M.; Nuccitelli, S.; Magrini, A.; Bergamaschi, A.; et al. Melatonin as an apoptosis antagonist. Ann. N. Y. Acad. Sci. 2006, 1090, 226-233.
19. Cos, S.; Mediavilla, M.D.; Fernández, R.; González-Lamuño, D.; Sánchez-Barceló, E.J. Does melatonin induce apoptosis in MCF-7 human breast cancer cells in vitro? J. Pineal. Res. 2002, 32, 90-96.
20. Cucina, A.; Proietti, S.; D'Anselmi, F.; Coluccia, P.; Dinicola, S.; Frati, L.; Bizzarri, M. Evidence for a biphasic apoptotic pathway induced by melatonin in MCF-7 breast cancer cells. J. Pineal. Res. 2009, 46, 172-180.
21. Mao, L.; Cheng, Q.; Guardiola-Lemaître, B.; Schuster-Klein, C.; Dong, C.; Lai, L.; Hill, S.M. In vitro and in vivo antitumor activity of melatonin receptor agonists. J. Pineal. Res. 2010, 49, 210-221.
22. Yang, Q.H.; Xu, J.-N.; Xu, R.K.; Pang, S.F. Antiproliferative effects of melatonin on the growth of rat pituitary prolactin-secreting tumor cells in vitro. J. Pineal. Res. 2007, 42, 172-179.
23. Esposito, E.; Iacono, A.; Muià, C.; Crisafulli, C.; Raso, G.M.; Bramanti, P.; Meli, R.; Cuzzocrea, S. Signal transduction pathways involved in protective effects of melatonin in C6 glioma cells. J. Pineal. Res. 2008, 44, 78-87.
24. Roth, J.A.; Rabin, R.; Agnello, K. Melatonin suppression of PC12 cell growth and death. Brain Res. 1997, 768, 63-70.
25. Ying, S.W.; Niles, L.P.; Crocker, C. Human malignant melanoma cells express high-affinity receptors for melatonin: Antiproliferative effects of melatonin and 6-chloromelatonin. Eur. J. Pharmacol. 1993, 246, 89-96.
26. Hu, D.N.; Roberts, J.E. Melatonin inhibits growth of cultured human uveal melanoma cells. Melanoma Res. 1997, 7, 27-31.
27. Hu, D.N.; McCormick, S.A.; Roberts, J.E. Effects of melatonin, its precursors and derivatives on the growth of cultured human uveal melanoma cells. Melanoma Res. 1998, 8, 205-210.
28. Helton, R.A.; Harrison, W.A.; Kelley, K.; Kane, M.A. Melatonin interactions with cultured murine B16 melanoma cells. Melanoma Res. 1993, 3, 403-413.
29. Cos, S.; Garcia-Bolado, A.; Sánchez-Barceló, E.J. Direct antiproliferative effects of melatonin on two metastatic cell sublines of mouse melanoma (B16BL6 and PG19). Melanoma Res. 2001, 11, 197-201.
30. Fischer, T.W.; Zmijewski, M.A.; Zbytek, B.; Sweatman, T.W.; Slominski, R.M.; Wortsman, J.; Slominski, A. Oncostatic effects of the indole melatonin and expression of its cytosolic and nuclear receptors in cultured human melanoma cell lines. Int. J. Oncol. 2006, 29, 665-672.
31. Panzer, A.; Lottering, M.L.; Bianchi, P.; Glencross, D.K.; Stark, J.H.; Seegers, J.C. Melatonin has no effect on the growth, morphology or cell cycle of human breast cancer (MCF-7), cervical cancer (HeLa), osteosarcoma (MG-63) or lymphoblastoid (TK6) cells. Cancer Lett. 1998, 122, 17-23.
32. Yerneni, L.K.; Jayaraman, S. Pharmacological action of high doses of melatonin on B16 murine melanoma cells depends on cell number at time of exposure. Melanoma Res. 2003, 13, 113-117.
33. Mengeaud, V.; Skene, D.; Pévet, P.; Ortonne, J.P. No high affinity melatonin binding sites are detected in murine melanoma cells and in normal human melanocytes cultured in vitro. Melanoma Res. 1994, 4, 87-91.
34. Carbajo-Pescador, S.; García-Palomo, A.; Martín-Renedo, J.; Piva, M.; González-Gallego, J.; Mauriz, J.L. Melatonin modulation of intracellular signaling pathways in hepatocarcinoma HepG2 cell line: Role of the MT1 receptor. J. Pineal. Res. 2011, 51, 463-471.
35. Barlow-Walden, L.R.; Reiter, R.J.; Abe, M.; Pablos, M.; Menendez-Pelaez, A.; Chen, L.D.; Poeggeler, B. Melatonin stimulates brain glutathione peroxidase activity. Neurochem. Int. 1995, 26, 497-502.
36. Rodriguez, C.; Mayo, J.C.; Sainz, R.M.; Antolín, I.; Herrera, F.; Martín, V.; Reiter, R.J. Regulation of antioxidant enzymes: A significant role for melatonin. J. Pineal. Res. 2004, 36, 1-9.
37. Leon, J.; Acuña-Castroviejo, D.; Sainz, R.M.; Mayo, J.C.; Tan, D.-X.; Reiter, R.J. Melatonin and mitochondrial function. Minireview. Life Sci. 2004, 75, 765-790.
38. Morrey, K.M.; McLachlan, J.A.; Serkin, C.D.; Bakouche, O. Activation of human monocytes by the pineal hormone melatonin. J. Immunol. 1994, 153, 2671-2680.
39. Radogna, F.; Paternoster, L.; de Nicola, M.; Cerella, C.; Ammendola, S.; Bedini, A.; Tarzia, G.; Aquilano, K.; Ciriolo, M.; Ghibelli, L. Rapid and transient stimulation of intracellular reactive oxygen species by melatonin in normal and tumor leukocytes. Toxicol. Appl. Pharmacol. 2009, 239, 37-45.
40. Cristofanon, S.; Uguccioni, F.; Cerella, C.; Radogna, F.; Dicato, M.; Ghibelli, L.; Diederich, M. Intracellular prooxidant activity of melatonin induces a survival pathway involving NF-κB activation. Ann. N. Y. Acad. Sci. 2009, 1171, 472-478.
41. García-Mauriño, S.; González-Haba, M.G.; Calvo, J.R.; Goberna, R.; Guerrero, J.M. Involvement of nuclear binding sites for melatonin in the regulation of IL-2 and IL-6 production by human blood mononuclear cells. J. Neuroimmunol. 1998, 92, 76-84.
42. Kühlwein, E.; Irwin, M. Melatonin modulation of lymphocyte proliferation and Th1/Th2 cytokine expression. J. Neuroimmunol. 2001, 117, 51-57.
43. Espino, J.; Bejarano, I.; Paredes, S.D.; Barriga, C.; Rodríguez, A.B.; Pariente, J.A. Protective effect of melatonin against human leukocyte apoptosis induced by intracellular calcium overload: Relation with its antioxidant actions. J. Pineal. Res. 2011, 51, 195-206.
44. Bejarano, I.; Redondo, P.C.; Espino, J.; Rosado, J.A.; Paredes, S.D.; Barriga, C.; Reiter, R.J.; Pariente, J.A.; Rodríguez, A.B. Melatonin induces mitochondrial-mediated apoptosis in human myeloid HL-60 cells. J. Pineal. Res. 2009, 46, 392-400.
45. Bejarano, I.; Espino, J.; Barriga, C.; Reiter, R.J.; Pariente, J.A.; Rodríguez, A.B. Pro-oxidant Effect of Melatonin in Tumor Leucocytes: Relation with its Cytotoxic and Pro-Apoptotic Effects. Basic Clin. Pharmacol. Toxicol. 2011, 108, 14-20.
46. Osseni, R.A.; Rat, P.; Bogdan, A.; Warnet, J.M.; Touitou, Y. Evidence of prooxidant and antioxidant action of melatonin on human liver cell line HepG2. Life Sci. 2000, 68, 387-399.
47. Albertini, M.C.; Radogna, F.; Accorsi, A.; Uguccioni, F.; Paternoster, L.; Cerella, C.; de Nicola, M.; D'Alessio, M.; Bergamaschi, A.; Magrini, A.; et al. Intracellular pro-oxidant activity of melatonin deprives U937 cells of reduced glutathione without affecting glutathione peroxidase activity. Ann. N. Y. Acad. Sci. 2006, 1091, 10-16.
48. Zhang, H.M.; Zhang, Y.; Zhang, B.X. The role of mitochondrial complex III in melatonininduced ROS production in cultured mesangial cells. J. Pineal. Res. 2011, 50, 78-82.
49. Zwirska-Korczala, K.; Jochem, J.; Adamczyk-Sowa, M.; Sowa, P.; Polaniak, R.; Birkner, E.; Latocha, M.; Pilc, K.; Suchanek, R. Influence of melatonin on cell proliferation, antioxidative enzyme activities and lipid peroxidation in 3T3-L1 preadipocytes-an in vitro study. J. Physiol. Pharmacol. 2005, 56, 91-99.
50. Nah, S.S.; Won, H.J.; Park, H.J.; Ha, E.; Chung, J.H.; Cho, H.Y.; Baik, H.H. Melatonin inhibits human fibroblast-like synoviocyte proliferation via extracellular signal-regulated protein kinase/P21(CIP1)/P27(KIP1) pathways. J. Pineal. Res. 2009, 47, 70-74.
51. Carossino, A.M.; Lombardi, A.; Matucci-Cerinic, M.; Pignone, A.; Cagnoni, M. Effect of melatonin on normal and sclerodermic skin fibroblast proliferation. Clin. Exp. Rheumatol. 1996, 14, 493-498.
52. Xie, Y.F.; Zhang, J.C.; Liu, S.J.; Dai, L.B.; Du, G.W. Effect of melatonin on proliferation and apoptosis of fibroblasts in human hypertrophic scar. Zhonghua Shao Shang Za Zhi 2011, 27, 422-426.
53. Alvarez-García, V.; González, A.; Alonso-González, C.; Martínez-Campa, C.; Cos, S. Regulation of vascular endothelial growth factor by melatonin in human breast cancer cells. J. Pineal. Res. 2012, doi:10.1111/jpi.12007.
54. González, A.; Alvarez-García, V.; Martínez-Campa, C.; Alonso-González, C.; Cos, S. Melatonin promotes differentiation of 3T3-L1 fibroblasts. J. Pineal. Res. 2012, 52, 12-20.
55. Izykowska, I.; Cegielski, M.; Gebarowska, E.; Podhorska-Okolow, M.; Piotrowska, A.; Zabel, M.; Dziegiel, P. Effect of melatonin on human keratinocytes and fibroblasts subjected to UVA and UVB radiation in vitro. In Vivo 2009, 23, 739-745.
56. Capoluongo, E. Insulin-like growth factor system and sporadic malignant melanoma. Am. J. Pathol. 2011, 178, 26-31.
57. Ucar, D.A.; Kurenova, E.; Garrett, T.J.; Cance, W.G.; Nyberg, C.; Cox, A.; Massoll, N.; Ostrov, D.A.; Lawrence, N.; Sebti, S.M.; et al. Disruption of the protein interaction between FAK and IGF-1R inhibits melanoma tumor growth. Cell Cycle 2012, 11, 3250-3259.
58. Ellerhorst, J.A.; Diwan, A.H.; Dang, S.M.; Uffort, D.G.; Johnson, M.K.; Cooke, C.P.; Grimm, E.A. Promotion of melanoma growth by the metabolic hormone leptin. Oncol. Rep. 2010, 23, 901-907.
59. Kadekaro, A.L.; Andrade, L.N.; Floeter-Winter, L.M.; Rollag, M.D.; Virador, V.; Vieira, W.; Castrucci, A.M. MT-1 melatonin receptor expression increases the antiproliferative effect of melatonin on S-91 murine melanoma cells. J. Pineal. Res. 2004, 36, 204-211.
60. Slominski, A.; Pruski, D. Melatonin inhibits proliferation and melanogenesis in rodent melanoma cells. Exp. Cell Res. 1993, 206, 189-194.
61. Pickering, D.S.; Niles, L.P. Expression of nanomolar-affinity binding sites for melatonin in Syrian hamster RPMI 1846 melanoma cells. Cell Signal. 1992, 4, 201-207.
62. Eison, A.S.; Mullins, U.L. Melatonin binding sites are functionally coupled to phosphoinositide hydrolysis in Syrian hamster RPMI 1846 melanoma cells. Life Sci. 1993, 53, PL393-PL398.
63. Souza, A.V.; Visconti, M.A.; Castrucci, A.M. Melatonin biological activity and binding sites in human melanoma cells. J. Pineal. Res. 2003, 34, 242-248.
64. Danielczyk, K.; Dziegiel, P. The expression of MT1 melatonin receptor and Ki-67 antigen in melanoma malignum. Anticancer Res 2009, 29, 3887-3895.
65. + and cADP-ribose in melatonin signal transduction. Mol. Cell Endocrinol. 1998, 137, 59-67.
66. Bubis, M.; Zisapel, N. Involvement of cGMP in cellular melatonin responses. Biol. Cell 1999, 91, 45-49.
67. Bubis, M.; Anis, Y.; Zisapel, N. Enhancement by melatonin of GTP exchange and ADP ribosylation reactions. Mol. Cell Endocrinol. 1996, 123, 139-148.
68. Blask, D.E.; Sauer, L.A.; Dauchy, R.T. Melatonin as a chronobiotic/ anticancer agent: Cellular, biochemical, and molecular mechanisms action and their implications for circadian-based cancer therapy. Curr. Top Med. Chem. 2002, 2, 113-132.
69. Benítez-King, G.; Soto-Vega, E.; Ramírez-Rodriguez, G. Melatonin modulates microfilament phenotypes in epithelial cells: Implications for adhesion and inhibition of cancer cell migration. Histol. Histopathol. 2009, 24, 789-799.
70. Hardeland, R.; Poeggeler, B.; Pappolla, M.A. Mitochondrial actions of melatonin-An endeavor to identify their adaptive and cytoprotective mechanisms. Proc. Saxon Acad. Sci. 2009, 65, 14-31.
71. Hardeland, R. Melatonin, mitochondrial electron flux and leakage: Recent findings and resolution of contradictory results. Adv. Stud. Biol. 2009, 1, 207-230.
72. Hardeland, R. Melatonin and its metabolites as anti-nitrosating and anti-nitrating agents. J. Exp. Integ. Med. 2011, 1, 67-81.
73. Chen, T.R. In situ detection of Mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain. Exp. Cell Res. 1977, 104, 255-262.
74. Denizot, F.; Lang, R. Rapid colorimetric assay for cell growth and survival. J. Inmunol. Methods 1986, 89, 271-277.
75. Osseni, R.A.; Debbasch, C.; Christen, M.-O.; Rat, P.; Warnet, J.-M. Tacrine induced reactive oxygen species in a human liver cell line: The role of athenole dithiolethione as a scavenger. Toxicol. In Vitro 1999, 13, 683-688.
76. Cole, E.R.; Crank, G. The estimation of melatonin in blood serum. Biochem. Med. 1972, 8, 37-43.